Targeting heterotopic ossification by inhibiting activin receptor‑like kinase 2 function (Review)

Prophylaxis of heterotopic ossification – an updated review

Heterotopic ossification (HO) is defined as the process by which trabecular bone forms outside of the skeletal structure, occupying space in soft tissue where it does not normally exist. The current popular prophylactic treatment modalities include non-steroidal anti-inflammatory drugs (NSAIDs) and radiation therapy, although the literature remains inconclusive as to which is superior. Addition...

Heterotopic Ossification

Heterotopic Ossification

Heterotopic ossification is a complicated and significant medical problem characterized by abnormal growth of bone in soft tissues. It occurs most commonly around a joint following surgery or trauma and is one of only a few benign conditions commonly treated with radiation therapy. In its severe form, the condition causes pain, loss of function, and restricted range of motion in the affected jo...

Heterotopic Ossification & Venous Thromboembolism

Heterotopic ossification (HO) is the formation of pathologic bone within soft tissues, often muscle tissues, where bone formation does not usually occur (Watanabe & Sant 2001). The incidence of HO in patients with traumatic brain injury (TBI) has been reported to range from 11–77% but is clinically relevant in 10–20% (Dizdar et al. 2013; Garland et al. 1980; Rogers 1988; Sarafis et al. 1999; Sa...

Heterotopic Ossification in Paraplegia

This paper is based on study over twelve and a half years of 170 patients suffering from traumatic paraplegia or tetraplegia, ofwhom 162 survived for more than a month after injury, and of 103 patients with other lesions of the spinal cord. The patients in the second group were less suitable for analysis because in many the lesions were disseminated or incomplete: few could be compared with the...